Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRLH | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-07 |
mRNA | ASAP2 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | CHTOP | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | PNISR | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | FAM189B | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | PLA1A | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-07 |
mRNA | NOL9 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | ARL6IP5 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-07 |
mRNA | KRT19 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |